Knowledge Hub

Global Peptic Ulcer Drugs Market Will Hit At CAGR Of 2.80% During Years 2017-2021

Press release   •   Jul 10, 2017 04:59 EDT

About peptic ulcer drugs market

A peptic ulcer is an open lesion, which develops on the mucosal lining of the stomach and the small intestine due to the caustic effect of the gastric acid and pepsin present in these organs. The general symptoms of a peptic ulcer include abdominal pain, nausea, vomiting, and bloated stomach. The specific symptom of peptic ulcer is the bleeding of the ulcer, which can be life-threatening. It is detected by bloody and sticky stools, often black in color. It is caused mainly by the Helicobacter pylori bacteria followed by the overuse of over-the-counter (OTC) non-steroidal anti-inflammatory drugs (NSAIDs) like naproxen, aspirin, and ibuprofen.

Technavios analysts forecast the global peptic ulcer drugs market to grow at a CAGR of 2.80% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global peptic ulcer drugs market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

Get Sample Copy Of This Report @ https://www.marketresearchreports.biz/sample/sample/1217099

Technavio's report, Global Peptic Ulcer Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

AstraZeneca,

Daewoong Pharmaceuticals,

Eisai,

Takeda Pharmaceutical

Other prominent vendors

GlaxoSmithKline

Pfizer

View Report @

https://www.marketresearchreports.biz/reports/1217099/global-peptic-ulcer-drugs-market-research-reports

Market driver

Economics of treating ulcer

For a full, detailed list, view our report

Market challenge

Adverse effect of PPIs

For a full, detailed list, view our report

Market trend

Bismuth-based quadruple therapy

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2021 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

Send An Enquiry Request @ https://www.marketresearchreports.biz/sample/enquiry/1217099

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

Market outline

PART 05: Peptic ulcers: Disease overview

PART 06: Key clinical trials

PART 07: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 08: Market segmentation by drug class

PPIs

Antibiotics

Others

PART 09: Geographical segmentation

Peptic ulcer drugs market in Americas

Peptic ulcer drugs market in EMEA

Peptic ulcer drugs market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges

Market drivers

Market challenges

PART 12: Market trends

Bismuth-based quadruple therapy

Emergence of monotherapy

Recurrent H. pylori infections

Rise in awareness

PART 13: Vendor landscape

Competitive scenario


MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.